Detalles de la búsqueda
1.
Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis.
Jpn J Clin Oncol
; 53(1): 35-45, 2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36156086
2.
A Phase II Study of Fulvestrant 500 mg as Maintenance Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Patients with Advanced Breast Cancer After First-Line Chemotherapy.
Oncologist
; 26(5): e742-e748, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245164
3.
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment: The SYSUCC-001 Randomized Clinical Trial.
JAMA
; 325(1): 50-58, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300950
4.
Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patients.
Cancer Immunol Immunother
; 67(11): 1743-1752, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30167861
5.
[Effects of Modified Ruji Recipe in Preventing Relapse and Metastasis of Breast Cancer Patients with Negative Hormone Receptor].
Zhongguo Zhong Xi Yi Jie He Za Zhi
; 37(2): 169-173, 2017 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-30650268
6.
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
Int J Cancer
; 135(8): 1961-9, 2014 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24604288
7.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.
Nat Med
; 30(1): 249-256, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191615
8.
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.
Breast Cancer (Dove Med Press)
; 16: 223-231, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38628818
9.
Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial.
EClinicalMedicine
; 64: 102240, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37767191
10.
Comparison of regulatory networks of E74-like factor 1 and cold-shock domain-containing E1 in breast cancer cell lines using ChIP datasets.
Exp Ther Med
; 20(6): 245, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33178343
11.
Development and validation of a nomogram in survival prediction among advanced breast cancer patients.
Ann Transl Med
; 8(21): 1446, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33313191
12.
The novel long noncoding RNA PRNCR12 is involved in breast cancer cell proliferation, migration, invasion and cell cycle progression.
Mol Med Rep
; 19(3): 1824-1832, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592261
13.
Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes.
Cancer Med
; 8(5): 2074-2084, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982232
14.
ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.
Cancer Med
; 7(8): 3862-3874, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936709
Resultados
1 -
14
de 14
1
Próxima >
>>